Today: 14 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Nokia Stock Snaps Back After Selloff, But Its AI Bet Faces a Hard Test

Nokia Stock Snaps Back After Selloff, But Its AI Bet Faces a Hard Test

Nokia Oyj’s U.S.-listed shares rose on Friday, recovering part of a sharp mid-week drop as investors kept buying into the Finnish group’s shift toward AI data-centre networking. Its ADR — a U.S.-traded receipt for a foreign share — closed up 3.81% at $12.82, beating the Nasdaq Composite’s 1.71% gain, with volume of 95.9 million shares, MarketWatch reported.
No Alcohol at CocoCay on May 12: Royal Caribbean Guests Face Bahamas Election Rule

No Alcohol at CocoCay on May 12: Royal Caribbean Guests Face Bahamas Election Rule

Royal Caribbean Cruises Ltd. guests headed to CocoCay on Tuesday, May 12, won’t be able to purchase alcohol onshore, with the Bahamas imposing an election-day liquor ban that also applies to private cruise islands. According to the company, both Perfect Day at CocoCay and Royal Beach Club Paradise Island will still be open that day. A Royal Caribbean spokesperson said the cruise line is “respecting and complying with all local laws and regulations.”
9 May 2026
Realty Income Stock: 150 Million-Share Sale Plan Puts Dividend REIT’s Growth Push in Focus

Realty Income Stock: 150 Million-Share Sale Plan Puts Dividend REIT’s Growth Push in Focus

Realty Income Corp has rolled out a fresh stock-sale program, setting itself up to potentially sell as many as 150 million common shares. The real estate investment trust is moving to boost its public equity firepower only days after lifting its 2026 investment goal. According to a May 8 filing, the San Diego-based firm struck a sales agreement with a lengthy roster of banks and brokers for both at-the-market and forward-sale deals.
Zoom Communications Stock Is Back Near Highs. Earnings Will Test the AI Push

Zoom Communications Stock Is Back Near Highs. Earnings Will Test the AI Push

Zoom Communications Inc. wrapped up Friday trading just shy of the session high, with shares settling at $109.21—an uptick from Thursday's $108.36 close. The collaboration-software stock reached $109.41 at its intraday peak, company market data indicated. That move adds a bit of steam ahead of the company’s next earnings report, now less than two weeks away.
NextEra Energy (NEE) AI Power Bet Hits Kansas Data Center Snag

NextEra Energy (NEE) AI Power Bet Hits Kansas Data Center Snag

Officials in Sedgwick County, Kansas, have pushed back the deadline for lifting a freeze on new data center applications to Sept. 11. That move keeps development on hold locally, even as NextEra Energy Inc. remains linked to land activity in the region for potential major computing sites. Local public radio noted both NextEra and Monarch Energy have either purchased or been working on deals for properties in Garden Plain, Colwich, and Andale, all just west of Wichita.
1 87 88 89 90 91 881

Stock Market Today

  • Cochlear gets FDA nod for rechargeable Osia 3, investors weigh outlook
    July 14, 2026, 2:20 PM EDT. Cochlear Limited picked up FDA clearance for its Osia 3 Sound Processor, a fully rechargeable bone conduction device that runs up to 30 hours. The Osia 3 brings wider fitting ranges and more connectivity, including Auracast broadcast audio. The launch reinforces Cochlear's focus on upgrades and service revenue in the U.S., but near-term headwinds remain with slower growth, pricing pressure in China, and higher fixed costs. Cochlear guides to A$2.7 billion in revenue and A$402.8 million earnings by 2029, looking for 4.4% growth yearly. Analyst views on revenue and profit gains are mixed. Investors are weighing if Osia 3 and new products can shift Cochlear's longer-term story given these risks.
Go toTop